These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8159582)

  • 1. [Magnesium in the prophylaxis of primary headache and other periodic disorders in children].
    Castelli S; Meossi C; Domenici R; Fontana F; Stefani G
    Pediatr Med Chir; 1993; 15(5):481-8. PubMed ID: 8159582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fever as periodic disorder].
    Castelli S; Domenici R; Meossi C; Stefani G
    Pediatr Med Chir; 1992; 14(4):399-402. PubMed ID: 1461778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of periodic syndrome and spasmophilia].
    Castelli S; Boresi T; Domenici R; Meossi C; Fontana F
    Pediatr Med Chir; 1992; 14(3):305-9. PubMed ID: 1528799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain among children and adolescents: restrictions in daily living and triggering factors.
    Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
    Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity of other pains in schoolchildren with migraine or nonmigrainous headache.
    Anttila P; Metsähonkala L; Mikkelsson M; Helenius H; Sillanpää M
    J Pediatr; 2001 Feb; 138(2):176-80. PubMed ID: 11174613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of a multidisciplinary approach to pediatric migraine at 1, 2, and 5 years.
    Kabbouche MA; Powers SW; Vockell AL; LeCates SL; Ellinor PL; Segers A; Manning P; Burdine D; Hershey AD
    Headache; 2005; 45(10):1298-303. PubMed ID: 16324161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, characteristics and distinctiveness of headaches in children from Vojvodina, Serbia.
    Knezević-Pogancev M
    Neuroepidemiology; 2008; 31(2):122-8. PubMed ID: 18716408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
    Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
    Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in migraine prophylaxis.
    Göbel H
    J Neurol; 2004 Feb; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
    Tepper SJ; Dahlöf CG; Dowson A; Newman L; Mansbach H; Jones M; Pham B; Webster C; Salonen R
    Headache; 2004 Oct; 44(9):856-64. PubMed ID: 15447694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.
    Young W; Shaw J; Bloom M; Gebeline-Myers C
    Headache; 2008; 48(10):1490-8. PubMed ID: 19076647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid in migraine prophylaxis of young patients. Three new reports.
    Fusco C; Pisani F; Capone C; Faienza C
    Acta Biomed; 2002; 73(3-4):47-51. PubMed ID: 12596387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.
    Nelson CF; Bronfort G; Evans R; Boline P; Goldsmith C; Anderson AV
    J Manipulative Physiol Ther; 1998 Oct; 21(8):511-9. PubMed ID: 9798179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.